M-D Building Products is fortunate to have significant growth opportunities and our investment will enable the company to meet its capital needs.
Cleveland, OH (PRWEB) July 22, 2015
Cyprium Partners, a non-control private equity firm, is pleased to announce its new sponsorless mezzanine investment in M-D Building Products. The capital was used to refinance existing indebtedness and to fund the company’s growth. This investment was Cyprium’s fifth transaction from its Cyprium Investors IV fund, which closed in December 2014.
Founded in 1920 and headquartered in Oklahoma City, M-D Building Products is the U.S. market leader in do-it-yourself (DIY) weatherization products used to reduce energy leaks around windows and doors (see http://www.mdteam.com). In addition to weatherization, M-D manufactures and distributes flooring tools and accessories, professional grade caulk and adhesives, and engineered components. The Company’s products are sold through leading hardware chains, specialty distributors and OEMs. The company maintains nine manufacturing and distribution facilities in the U.S. and Canada.
“Cyprium is very excited to provide growth capital to the owners and management team at M-D Building Products,” said Beth Haas Laschinger, a Partner at Cyprium Partners. “Loren Plotkin and his team have built the company into a leading weatherization and flooring accessory company through their commitment to product innovation and excellent customer service. M-D Building Products is fortunate to have significant growth opportunities and our investment will enable the company to meet its capital needs. We look forward to a long and collaborative relationship with M-D, its management, and employees.”
About Cyprium Partners
Cyprium Partners is a private equity firm focused on non-control (minority ownership) investments. Cyprium utilizes a combination of subordinated debt, preferred stock, and/or common stock to enable privately-held businesses, entrepreneurs, and management teams to achieve their financial and strategic objectives. With offices in Cleveland, New York, and Chicago, the firm invests $10 million to $60 million per transaction in U.S. and Canadian companies with $10 million or more of EBITDA. Learn more about Cyprium Partners at http://www.cyprium.com.